---
figid: PMC4063399__onc9991113360002
figtitle: Resistance to vemurafenib
organisms:
- NA
pmcid: PMC4063399
filename: onc9991113360002.jpg
figlink: /pmc/articles/PMC4063399/figure/F2/
number: F2
caption: 'Resistance to vemurafenib. (A): Resistance to targeted oncogene inhibition
  can occur through oncogene reactivation or activation of a bypass pathway. (B):
  Clinical resistance to vemurafenib. Seven mechanisms, most of which reactivate MAPK
  signaling, have been described.'
papertitle: 'Ipilimumab, Vemurafenib, Dabrafenib, and Trametinib: Synergistic Competitors
  in the Clinical Management of BRAF Mutant Malignant Melanoma.'
reftext: Jason J. Luke, et al. Oncologist. 2013 Jun;18(6):717-725.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7975011
figid_alias: PMC4063399__F2
figtype: Figure
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
redirect_from: /figures/PMC4063399__F2
ndex: 323865df-df17-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4063399__onc9991113360002.html
  '@type': Dataset
  description: 'Resistance to vemurafenib. (A): Resistance to targeted oncogene inhibition
    can occur through oncogene reactivation or activation of a bypass pathway. (B):
    Clinical resistance to vemurafenib. Seven mechanisms, most of which reactivate
    MAPK signaling, have been described.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PDGFRB
  - IGF1
  - BRAF
  - HGF
  - IL6
  - SOS1
  - KRAS
  - HRAS
  - NRAS
  - XYLT2
  - SOS2
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MAP3K8
  - CROT
  - EPHB2
  - MAPK1
  - MAPK3
  - Tie
  - Ras85D
  - InR
  - ras
  - Ras64B
  - grb
  - Sos
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Dsor1
  - Mtk
  - mir-ban
  - Erk7
  - rl
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
